<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Long-term Follow up of Diclofenac  Sodium 3% in 2.5% Hyaluronic Acid Gel for Actinic Keratosis: One-year Evaluation</title>
	<atom:link href="http://www.jcadonline.com/long-term-follow-up-of-diclofenac-sodium-3-in-25-hyaluronic-acid-gel-for-actinic-keratosis-one-year-evaluation/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.jcadonline.com/long-term-follow-up-of-diclofenac-sodium-3-in-25-hyaluronic-acid-gel-for-actinic-keratosis-one-year-evaluation/</link>
	<description>The Journal of Clinical and Aesthetic Dermatology (JCAD)</description>
	<lastBuildDate>Tue, 31 Jan 2012 20:12:13 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Lynn Scarlett</title>
		<link>http://www.jcadonline.com/long-term-follow-up-of-diclofenac-sodium-3-in-25-hyaluronic-acid-gel-for-actinic-keratosis-one-year-evaluation/comment-page-1/#comment-1132</link>
		<dc:creator>Lynn Scarlett</dc:creator>
		<pubDate>Tue, 11 Aug 2009 02:04:11 +0000</pubDate>
		<guid isPermaLink="false">http://www.jcadonline.com/?p=1683#comment-1132</guid>
		<description>At first read this data looks interesting until a critical examination of the methods brings a need for further studies.  This study is done with no placebo control and isn&#039;t blinded.  Further, it would be valuable to begin as an intent to treat trial and, if comparing to Krawtchenko N, Roewert-Huber J, Ulrich M, et al. Br J Dermatol 2007; 157 (suppl 2): 34-40., should also contain histological results.</description>
		<content:encoded><![CDATA[<p>At first read this data looks interesting until a critical examination of the methods brings a need for further studies.  This study is done with no placebo control and isn&#8217;t blinded.  Further, it would be valuable to begin as an intent to treat trial and, if comparing to Krawtchenko N, Roewert-Huber J, Ulrich M, et al. Br J Dermatol 2007; 157 (suppl 2): 34-40., should also contain histological results.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

